Cargando…

Future Costs in Cost-Effectiveness Analyses: Past, Present, Future

There has been considerable debate on the extent to which future costs should be included in cost-effectiveness analyses of health technologies. In this article, we summarize the theoretical debates and empirical research in this area and highlight the conclusions that can be drawn for current pract...

Descripción completa

Detalles Bibliográficos
Autores principales: de Vries, Linda M., van Baal, Pieter H. M., Brouwer, Werner B. F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6386050/
https://www.ncbi.nlm.nih.gov/pubmed/30474803
http://dx.doi.org/10.1007/s40273-018-0749-8
_version_ 1783397311498420224
author de Vries, Linda M.
van Baal, Pieter H. M.
Brouwer, Werner B. F.
author_facet de Vries, Linda M.
van Baal, Pieter H. M.
Brouwer, Werner B. F.
author_sort de Vries, Linda M.
collection PubMed
description There has been considerable debate on the extent to which future costs should be included in cost-effectiveness analyses of health technologies. In this article, we summarize the theoretical debates and empirical research in this area and highlight the conclusions that can be drawn for current practice. For future related and future unrelated medical costs, the literature suggests that inclusion is required to obtain optimal outcomes from available resources. This conclusion does not depend on the perspective adopted by the decision maker. Future non-medical costs are only relevant when adopting a societal perspective; these should be included if the benefits of non-medical consumption and production are also included in the evaluation. Whether this is the case currently remains unclear, given that benefits are typically quantified in quality-adjusted life-years and only limited research has been performed on the extent to which these (implicitly) capture benefits beyond health. Empirical research has shown that the impact of including future costs can be large, and that estimation of such costs is feasible. In practice, however, future unrelated medical costs and future unrelated non-medical consumption costs are typically excluded from economic evaluations. This is explicitly prescribed in some pharmacoeconomic guidelines. Further research is warranted on the development and improvement of methods for the estimation of future costs. Standardization of methods is needed to enhance the practical applicability of inclusion for the analyst and the comparability of the outcomes of different studies. For future non-medical costs, further research is also needed on the extent to which benefits related to this spending are captured in the measurement and valuation of health benefits, and how to broaden the scope of the evaluation if they are not sufficiently captured.
format Online
Article
Text
id pubmed-6386050
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-63860502019-03-12 Future Costs in Cost-Effectiveness Analyses: Past, Present, Future de Vries, Linda M. van Baal, Pieter H. M. Brouwer, Werner B. F. Pharmacoeconomics Leading Article There has been considerable debate on the extent to which future costs should be included in cost-effectiveness analyses of health technologies. In this article, we summarize the theoretical debates and empirical research in this area and highlight the conclusions that can be drawn for current practice. For future related and future unrelated medical costs, the literature suggests that inclusion is required to obtain optimal outcomes from available resources. This conclusion does not depend on the perspective adopted by the decision maker. Future non-medical costs are only relevant when adopting a societal perspective; these should be included if the benefits of non-medical consumption and production are also included in the evaluation. Whether this is the case currently remains unclear, given that benefits are typically quantified in quality-adjusted life-years and only limited research has been performed on the extent to which these (implicitly) capture benefits beyond health. Empirical research has shown that the impact of including future costs can be large, and that estimation of such costs is feasible. In practice, however, future unrelated medical costs and future unrelated non-medical consumption costs are typically excluded from economic evaluations. This is explicitly prescribed in some pharmacoeconomic guidelines. Further research is warranted on the development and improvement of methods for the estimation of future costs. Standardization of methods is needed to enhance the practical applicability of inclusion for the analyst and the comparability of the outcomes of different studies. For future non-medical costs, further research is also needed on the extent to which benefits related to this spending are captured in the measurement and valuation of health benefits, and how to broaden the scope of the evaluation if they are not sufficiently captured. Springer International Publishing 2018-11-26 2019 /pmc/articles/PMC6386050/ /pubmed/30474803 http://dx.doi.org/10.1007/s40273-018-0749-8 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Leading Article
de Vries, Linda M.
van Baal, Pieter H. M.
Brouwer, Werner B. F.
Future Costs in Cost-Effectiveness Analyses: Past, Present, Future
title Future Costs in Cost-Effectiveness Analyses: Past, Present, Future
title_full Future Costs in Cost-Effectiveness Analyses: Past, Present, Future
title_fullStr Future Costs in Cost-Effectiveness Analyses: Past, Present, Future
title_full_unstemmed Future Costs in Cost-Effectiveness Analyses: Past, Present, Future
title_short Future Costs in Cost-Effectiveness Analyses: Past, Present, Future
title_sort future costs in cost-effectiveness analyses: past, present, future
topic Leading Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6386050/
https://www.ncbi.nlm.nih.gov/pubmed/30474803
http://dx.doi.org/10.1007/s40273-018-0749-8
work_keys_str_mv AT devrieslindam futurecostsincosteffectivenessanalysespastpresentfuture
AT vanbaalpieterhm futurecostsincosteffectivenessanalysespastpresentfuture
AT brouwerwernerbf futurecostsincosteffectivenessanalysespastpresentfuture